Navigation Links
New AHRQ Resources Help Primary Care Clinicians Treat Alcohol Use Disorder
Date:2/16/2016

ROCKVILLE, Md., Feb. 16, 2016 /PRNewswire-USNewswire/ -- The Agency for Healthcare Research and Quality (AHRQ) today published two new resources to help primary care clinicians and their patients make evidence-based decisions about which medications to use for treating alcohol use disorder (AUD), the medical diagnosis for problem drinking that causes mild to severe distress or harm.

The new resources – a pair of research summaries designed to facilitate treatment discussions between clinicians and patients – will make it easier for primary care clinicians to work with their patients to make treatment decisions about medications used to treat AUD. Primary care providers are typically trained to refer patients with AUD for specialized treatment, and fewer than 10 percent of people treated for AUD receive medications currently.

In the United States, more than 68 million people 18 years old or older suffer from AUD at some point in their lifetime, according to data released by the National Institute on Alcohol Abuse and Alcoholism in August 2015. The disorder can lead to severe health problems and immeasurable personal and family suffering. It is the third modifiable risk factor that leads to early death, after tobacco use and being overweight; people with AUD are at least three times as likely to die early as those without AUD.

"These new resources, based on the most current research, will help clinicians and patients make informed choices about treatment in accordance with their own wishes and values," said AHRQ Director Rick Kronick, Ph.D.

The research summaries are based on findings from a 2014 review of the evidence on medication-based treatment of AUD. One summary is directed at clinicians and other health care providers to help them understand the evidence currently available so they can apply it on the front lines of care. The other summary is written in a way that can help patients and their families understand what their options are for medication-based treatments.

AHRQ's systematic review found moderate evidence that acamprosate (trade name: Campral) and oral naltrexone (Reviva, Vivitrol) improve outcomes for patients with AUD. Head-to-head comparisons have not consistently established the superiority of one medication over another, and evidence related to injectable naltrexone is limited. The review also found that the evidence from randomized, placebo-controlled trials does not support the effectiveness of disulfiram (Antabuse) for clinical outcomes, such as a return to any drinking and number of drinks/per drinking days, or for reducing amount of alcohol consumed. 

Most studies included in the review evaluated the use of medications in conjunction with psychosocial treatments; the use of medications alone has not been studied enough to draw conclusions, according to the review.

Conducted by researchers funded through AHRQ's Evidence-based Practice Center program, the review included studies on medicines to treat alcohol dependence and alcohol use disorder published between January 1970 and October 2013. The report included 135 studies, and findings were reviewed by health care professionals, researchers, experts and the public. The full report is available at www.effectivehealthcare.ahrq.gov/alcohol-disorder.

AHRQ's Evidence-based Practice Centers develop systematic reviews to help the public, clinicians and others who make decisions about health care improve the quality of care provided in the United States. These reviews provide comprehensive, science-based information on common, costly medical conditions and new health care technologies and strategies. Select findings from these reviews are translated into guides so that clinicians and patients can easily apply the findings on the front lines of care. These new AUD research summaries and other guides and systematic reviews can be found at www.effectivehealthcare.ahrq.gov.

AHRQ's mission is to produce evidence to make health care safer, higher quality, more accessible, equitable and affordable, and to work with Department of Health and Human Services and other partners to make sure that the evidence is understood and used. For more information about AHRQ, visit www.ahrq.gov.

 

 


'/>"/>
SOURCE Agency for Healthcare Research & Quality
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Orexigen Therapeutics names Thomas Lynch as EVP, General Counsel & Secretary and Heather Ace as EVP, Global Human Resources
2. Hospice Pharmacy Solutions completes merger with Outcome Resources
3. Sign Against Stroke Task Force Help to Address Medical, Physical, Mental and Financial Needs of People with Atrial Fibrillation with New Health Empowerment Resources
4. West Appoints Annette Favorite Senior Vice President and Chief Human Resources Officer
5. Decision Resources Groups Monique Levy Appointed to Google Healthcare Advisory Board
6. Decision Resources Group Projects the US Market for Diabetes Care Devices To Be Valued at Over $22 Billion by 2023
7. NxStage Launches New Spanish-Language Resources for Hispanic Patients
8. Impax Strengthens Leadership Team by Adding New Senior Vice Presidents for Human Resources and Compliance
9. Intarcia Appoints James P. Brady Vice President, Human Resources
10. Precyse Unlocks Revenue and Resources at HIMSS 2015
11. DigiPath Inc. Partners with Blue Line Protection Group to Share Resources and Develop Marketing Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2017)... Inc. (NYSE: DPLO), the nation,s largest independent specialty pharmacy, announced ... comparisons, unless otherwise noted, are to the quarter ended June ... Quarter 2017 Highlights include: Revenue of ... Total prescriptions dispensed of 220,000, compared to ... Gross profit per prescription dispensed of ...
(Date:8/3/2017)...  Opioid addiction and other drugs of abuse, blood ... threatening outcomes, were problems taken on directly as laboratory ... support them, met this week. This according to Kalorama ... of abuse, procalcitonin and acute kidney injury were key ... meeting in San Diego, CA. ...
(Date:8/2/2017)... Aug. 2, 2017 CaryRx, a next-generation full-service pharmacy, ... service for patients in the Washington D.C. ... pharmacy by providing delivery of medications through the convenience of ... delivery or delivered within one hour to any location in ... to bring this invaluable service to Washington D.C. ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... 2017 , ... “Kingdom Mandate for Kingdom Builders”: a call to walk as ... Builders” is the creation of published author, John F. McGeorge, Jr. Dr. John ... in 1983. He spent three decades training pastors and Christian leaders. He ...
(Date:8/18/2017)... ... 2017 , ... “Steve the Snake”: an entertaining and moral-based short story about ... published author, Harold Flash Haskins Jr., a husband, father and grandfather who served as ... “I write moral-based short stories for children and teens. My goal is to teach ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... practice, is adding a new location in Goldsboro, NC to its family of ... that is Riccobene Associates’ trademark starting August 15, 2017. , Riccobene Associates ...
(Date:8/17/2017)... ... August 17, 2017 , ... The award-winning producers ... feature the National Council for Therapeutic Recreation Certification (NCTRC), slated to air nationwide, ... 1981, NCTRC is a non-profit, international organization dedicated to professional excellence for the ...
(Date:8/17/2017)... Boston, MA (PRWEB) , ... August 17, 2017 ... ... investors will come together on September 19, 2017 for Anti-Infectives Rx. This off-the-record ... Joseph B. Martin Conference Center at Harvard Medical School. , Industry leaders and ...
Breaking Medicine News(10 mins):